It has been shown that bladder cancer cells rely on aerobic glycolysis as the main energy source [35]. Li et al. have reported that miR-218 increased the sensitivity of bladder cancer to cisplatin by targeting Glut1 [36]. This evidence concerns the gene SLC2A1 and urinary bladder carcinoma.